Clinical Reference Laboratory Testing Services

The Government is soliciting proposals for Clinical Reference Laboratory Testing Services under Solicitation Number HT001526RE001DRAFT, with the final solicitation expected within seven days of the draft release on May 6, 2026. The contract is a Firm Fixed Price (FFP) award to be made on a best-value tradeoff basis, not lowest price technically acceptable, emphasizing that non-price factors—Technical, Performance Risk, and Small Business Subcontracting Participation—are significantly more important than price. The scope requires comprehensive laboratory testing services across chemistry, hematology, microbiology, molecular, cytology, and genetic disciplines for Department of Defense beneficiaries, including specimen collection, transport, and reporting through integration with the MHS Genesis system. All services must meet strict compliance standards including CLIA, CAP accreditation, NIST SP 800-171, CMMC Level 2, and HIPAA, with cybersecurity protections governed by DFARS clauses on safeguarding covered defense information and compliance with the Cybersecurity Maturity Model Certification. The contract includes a five-year base period extending through June 2031 and a potential five-year option period, with transition periods of up to six months and a mandatory post-award conference. Proposals must be submitted in five clearly labeled email volumes—Business, Technical, Performance Risk, Small Business Subcontracting, and Price—with the Technical Proposal limited to 45 pages and all submissions adhering to file format requirements (.docx, .xlsx, PDF) and prohibited features such as password protection or read-only files. Offerors are required to comply with extensive personnel security obligations, including obtaining Common Access Cards, completing DoD OPSEC and Cyber Awareness training, undergoing NACLC-level security investigations, and adhering to strict controls over sensitive data including Protected Health Information and Controlled Unclassified Information. Key personnel must include a full-time project manager with a designated alternate, a 24/7 contractor representative, and trained technicians for specimen handling and system support. Economic Price Adjustment is possible only once during the option period if the BLS Producer Price Index for Medical and Diagnostic Laboratories increases 20% or more from award, subject to a 5% cumulative ceiling across all adjustments. Offerors must also represent their small business status, disclose potential foreign government ties or supply chain risks related to China or Maduro-regime entities, and ensure compliance with all FAR and DFARS clauses, including those governing whistleblower rights, labor standards, trafficking in persons, and payment to